Market Overview:
The global inhalational anesthesia drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing number of surgeries being performed and the growing demand for minimally invasive surgeries. In addition, the development of new inhalational anesthetics and rising awareness about their benefits are also contributing to the growth of this market. The global inhalational anesthesia drugs market is segmented on the basis of type, application, and region. On the basis of type, sevoflurane accounted for a major share in 2017 and is expected to maintain its dominance during the forecast period as well. This can be attributed to its low toxicity levels and easy availability across regions.
Product Definition:
Inhalational anesthetics are a class of drugs used to produce anesthesia. They are administered by inhalation, and most commonly used in surgery. Inhalational anesthetics work by depressing the central nervous system, which reduces sensation and pain.
Sevoflurane:
Sevoflurane, also known as sevoflurane/methanesulfonate, is an organic compound and a member of the class of compounds known as halogenated derivatives of flurbiprofen. It has a pungent odor similar to garlic and tastes slightly sweet. Sevoflurane is used in anesthesia for animals (including humans) due to its analgesic properties.
Desflurane:
Desflurane is an organic compound and an inhalational anesthesia gas. It has a sweetish odor with a hint of almond. Desflurane was first synthesized in 1839 by the German pharmacist Friedrich Konrad Beilstein, but it was not until 1848 that its structure was determined by French Chemist Louis-Nicolas Vauquelin.
Application Insights:
Based on application, the global inhalational anesthesia drugs market is segmented into hospitals, clinics and ambulatory surgical centers. Hospitals held the largest share in 2017 owing to factors such as a high prevalence of surgical procedures requiring anesthetic agents and increasing number of hospital births. In addition, favorable reimbursement policies for surgeries performed under general anesthesia are also expected to drive growth over the forecast period.
The clinics and ambulatory surgical centers segment is anticipated to witness significant growth during the forecast period due to factors such as growing awareness about pain management among patients suffering from chronic diseases or injuries along with an increase in recreational activities that require medical attention. Furthermore, these facilities offer non-invasive procedures making them popular among consumers seeking aesthetic treatments or dental work without having to go through major surgery at hospitals which further drives demand for inhalational anesthesia drugs across various regions globally.
Regional Analysis:
North America dominated the global inhalational anesthetic drugs market in 2017. This is owing to increasing use of inhalational agents for surgeries performed under conscious sedation and general anesthesia. In addition, rising number of procedural codes for surgical procedures that require use of inhaled anesthetics is also expected to drive growth over the forecast period.
Asia Pacific region is anticipated to witness rapid growth over the forecast period due to factors such as improving healthcare infrastructure and growing demand for surgery by a large population base in this region.
In 2016, around 1 billion people worldwide used prescription or non-prescription medicines containing volatile organic compounds (VOCs) for relaxation or sleep induction purposes; this number includes adults as well as children (under 18 years).
Growth Factors:
- Increasing incidence of surgery and other medical procedures: The global Inhalational Anesthesia Drugs market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of surgery and other medical procedures.
- Rising geriatric population: The global geriatric population is expected to increase significantly in the next few years, which will lead to an increase in the demand for inhalational anesthesia drugs.
- Technological advancements: The inhalational anesthesia drugs market is witnessing significant technological advancements, which is resulting in new product launches and increased adoption rates among physicians and patients alike. This is likely to drive market growth during the forecast period.
- Growing awareness about benefits of inhalational anesthesia drugs: There has been a growing awareness about the benefits of using inhalational anesthetics over general or regional anaesthetics among both physicians and patients across the globe, which is likely to fuel market growth during the forecast period.. 5) Stringent regulatory scenario for approval of new products: Stringent regulatory scenario for approval o
Scope Of The Report
Report Attributes
Report Details
Report Title
Inhalational Anesthesia Drugs Market Research Report
By Type
Sevoflurane, Desflurane, Isoflurane, Enflurane
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
Baxter, AbbVie, Piramal Enterprises, Halocarbon Products, Jiangsu Hengrui Medicine, Fresenius Kabi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Inhalational Anesthesia Drugs Market Report Segments:
The global Inhalational Anesthesia Drugs market is segmented on the basis of:
Types
Sevoflurane, Desflurane, Isoflurane, Enflurane
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- AbbVie
- Piramal Enterprises
- Halocarbon Products
- Jiangsu Hengrui Medicine
- Fresenius Kabi
Highlights of The Inhalational Anesthesia Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sevoflurane
- Desflurane
- Isoflurane
- Enflurane
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inhalational Anesthesia Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Inhalational anesthetics are drugs that block nerve impulses in the brain, causing a loss of consciousness.
Some of the key players operating in the inhalational anesthesia drugs market are Baxter, AbbVie, Piramal Enterprises, Halocarbon Products, Jiangsu Hengrui Medicine, Fresenius Kabi.
The inhalational anesthesia drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inhalational Anesthesia Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Inhalational Anesthesia Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Inhalational Anesthesia Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Inhalational Anesthesia Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Inhalational Anesthesia Drugs Market Size & Forecast, 2020-2028
4.5.1 Inhalational Anesthesia Drugs Market Size and Y-o-Y Growth
4.5.2 Inhalational Anesthesia Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Sevoflurane
5.2.2 Desflurane
5.2.3 Isoflurane
5.2.4 Enflurane
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Inhalational Anesthesia Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Inhalational Anesthesia Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Sevoflurane
9.6.2 Desflurane
9.6.3 Isoflurane
9.6.4 Enflurane
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Sevoflurane
10.6.2 Desflurane
10.6.3 Isoflurane
10.6.4 Enflurane
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Sevoflurane
11.6.2 Desflurane
11.6.3 Isoflurane
11.6.4 Enflurane
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Sevoflurane
12.6.2 Desflurane
12.6.3 Isoflurane
12.6.4 Enflurane
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Sevoflurane
13.6.2 Desflurane
13.6.3 Isoflurane
13.6.4 Enflurane
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Inhalational Anesthesia Drugs Market: Competitive Dashboard
14.2 Global Inhalational Anesthesia Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter
14.3.2 AbbVie
14.3.3 Piramal Enterprises
14.3.4 Halocarbon Products
14.3.5 Jiangsu Hengrui Medicine
14.3.6 Fresenius Kabi
